Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Kimsa-Dudek M et al. | 2021 | intact cell/cell culture, NHDF cells (normal human dermal fibroblasts) | static magnetic field, also other exposures without EMF, co-exposure | - |
| Kruszniewska-Rajs C et al. | 2021 | intact cell/cell culture, NHDF cells (normal human dermal fibroblasts) | static magnetic field, also other exposures without EMF, co-exposure | - |
| Kimsa-Dudek M et al. | 2024 | intact cell/cell culture, NHDF cells (normal human dermal fibroblasts) | static magnetic field, also other exposures without EMF, co-exposure | - |
| Ledda M et al. | 2013 | intact cell/cell culture, NT2 (human pluripotent embryonal carcinoma cells) | magnetic field, static magnetic field, low frequency | 2.5–10 µT |
| Lange S et al. | 2024 | intact cell/cell culture, PC3 cells (human prostate cancer cell line) and PNT2 cells (prostate epithelial cell line) | geomagnetic field, shielding/field deprivation | - |
| Huyan T et al. | 2020 | intact cell/cell culture, RAW 264.7 (murine pre-osteoclast cells) | static magnetic field | - |
| Dong D et al. | 2019 | intact cell/cell culture, RAW264.7 cells | static magnetic field | - |
| Mo W et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | static magnetic field, geomagnetic field, shielding/field deprivation | 111.1 nT |
| Kim S et al. | 2008 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) and PC-12 (neuroblastoma cells) | static magnetic field | 12 mT |
| Izzo L et al. | 2019 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) | static magnetic field | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
